Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study
- PMID: 30394248
- PMCID: PMC6518603
- DOI: 10.1017/S0950268818002923
Prevalence of comorbidities in cases of Middle East respiratory syndrome coronavirus: a retrospective study
Abstract
The Middle East respiratory syndrome coronavirus (MERS-CoV) is a life-threatening respiratory disease with a high case fatality rate; however, its risk factors remain unclear. We aimed to explore the influence of demographic factors, clinical manifestations and underlying comorbidities on mortality in MERS-CoV patients. Retrospective chart reviews were performed to identify all laboratory-confirmed cases of MERS-COV infection in Saudi Arabia that were reported to the Ministry of Health of Saudi Arabia between 23 April 2014 and 7 June 2016. Statistical analyses were conducted to assess the effect of sex, age, clinical presentation and comorbidities on mortality from MERS-CoV. A total of 281 confirmed MERS-CoV cases were identified: 167 (59.4%) patients were male and 55 (20%) died. Mortality predominantly occurred among Saudi nationals and older patients and was significantly associated with respiratory failure and shortness of breath. Of the 281 confirmed cases, 160 (56.9%) involved comorbidities, wherein diabetes mellitus, hypertension, ischemic heart disease, congestive heart failure, end-stage renal disease and chronic kidney disease were significantly associated with mortality from MERS-CoV and two or three comorbidities significantly affected the fatality rates from MERS-CoV. The findings of this study show that old age and the existence of underlying comorbidities significantly increase mortality from MERS-CoV.
Keywords: Comorbidities; middle east respiratory syndrome coronavirus; mortality.
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Zaki AM et al. (2012) Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. New England Journal of Medicine 367, 1814–1820. - PubMed
-
- (WHO), W.H.O (2017) WHO MERS-CoV Global Summary and Assessment of Risk. Available at http://www.who.int/emergencies/mers-cov/risk-assessment-july-2017.pdf.
LinkOut - more resources
Full Text Sources
Miscellaneous